Two Sigma Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,600
Closed -$759K 2727
2024
Q3
$759K Sell
6,600
-13,900
-68% -$1.58M 0.01% 1029
2024
Q2
$2.18M Buy
20,500
+18,000
+720% +$1.81M 0.03% 677
2024
Q1
$242K Sell
2,500
-27,900
-92% -$2.86M ﹤0.01% 2154
2023
Q4
$3.07M Buy
30,400
+10,600
+54% +$1.02M 0.03% 531
2023
Q3
$2.02M Buy
19,800
+15,700
+383% +$1.59M 0.02% 684
2023
Q2
$414K Buy
+4,100
New +$410K 0.01% 1581
2022
Q3
Sell
-7,000
Closed -$592K 2943
2022
Q2
$592K Buy
7,000
+4,400
+169% +$386K 0.02% 800
2022
Q1
$228K Buy
+2,600
New +$225K 0.01% 1641
2021
Q1
Sell
-4,000
Closed -$378K 1480
2020
Q4
$378K Sell
4,000
-1,700
-30% -$149K 0.01% 872
2020
Q3
$496K Buy
+5,700
New +$494K 0.01% 602
2020
Q1
Sell
-54,900
Closed -$5.2M 2015
2019
Q4
$5.2M Sell
54,900
-16,700
-23% -$1.5M 0.04% 385
2019
Q3
$6.22M Buy
71,600
+39,700
+124% +$3.56M 0.06% 266
2019
Q2
$2.91M Buy
31,900
+12,370
+63% +$1.05M 0.03% 360
2019
Q1
$1.68M Sell
19,530
-20,534
-51% -$1.65M 0.02% 377
2018
Q4
$3.08M Sell
40,064
-45,087
-53% -$3.51M 0.04% 244
2018
Q3
$6.57M Buy
85,151
+7,812
+10% +$578K 0.04% 310
2018
Q2
$5.24M Sell
77,339
-171,417
-69% -$11.8M 0.03% 487
2018
Q1
$18M Buy
248,756
+243,846
+4,966% +$18.6M 0.1% 175
2017
Q4
$369K Buy
+4,910
New +$370K 0.01% 877

Other funds holding NVS

Two Sigma Securities's NVS Position: Q3 2025 in Review

Two Sigma Securities sold out of Novartis (NVS) in Q3 2025, closing a stake of 2,808 shares — an estimated $340K sold.

Two Sigma Securities first reported a position in NVS in Q1 2017 and held it in 17 quarters. The position peaked at $10.7M in Q1 2018. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Two Sigma Securities reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 2,808 Novartis shares in Q3 2025, an estimated $340K.
  • Two Sigma Securities first reported a position in Novartis in Q1 2017 and held it in 17 quarters.
  • Two Sigma Securities's Novartis position peaked at $10.7M in Q1 2018.
  • 1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.